1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Sorrento Therapeutics Inc (SRNE)
  7. Quote


Sorrento Therapeutics Stock Price

-0.63 (-11.43%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 9,651,014
Bid Price 4.89
Ask Price 4.90
News (1)
Day High 5.58


52 Week Range


Day Low 4.92
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sorrento Therapeutics Inc SRNE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.63 -11.43% 4.88 19:59:53
Open Price Low Price High Price Close Price Prev Close
5.51 4.92 5.58 4.945 5.51
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
33,331 9,651,014 $ 5.11 $ 49,282,699 - 4.92 - 17.25
Last Trade Time Type Quantity Stock Price Currency
19:59:22 15 $ 4.88 USD


Draw Mode:

Sorrento Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.49B 306.34M 301.62M $ 39.99M $ - -1.30 -4.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 3.95M 34.60%

more financials information »

Sorrento Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SRNE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.916.174.925.765,286,490-1.03-17.43%
1 Month6.826.994.926.115,111,006-1.94-28.45%
3 Months8.058.2754.926.784,771,121-3.17-39.38%
6 Months8.4211.074.928.125,632,124-3.54-42.04%
1 Year7.7917.254.929.539,128,427-2.91-37.36%
3 Years3.5221.261.398.0911,558,6451.3638.64%
5 Years5.1521.261.397.867,571,631-0.27-5.24%

Sorrento Therapeutics Description

Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates.

Your Recent History
Sorrento T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.